Eui-Cheol Shin
KAIST
H-index: 62
Asia-South Korea
Top articles of Eui-Cheol Shin
Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
Genome Medicine
2024/1/31
Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants
Science immunology
2024/1/19
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in advanced biliary tract cancer
2024/1/10
GX-I7 (rhIL-7-hyFc, efineptakin alfa), a long-acting IL-7, safely and effectively increased peripheral CD8+ and CD4+ T cells and TILs in patients with solid tumors
medRxiv
2024
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma
Journal for Immunotherapy of Cancer
2024
Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF
Journal of Clinical Immunology
2024/4
A selective HPK1 inhibitor FB849 reprograms intratumoral immune cells and elicits strong anti-cancer immunity
Cancer Research
2024/3/22
Seung Hyuck Jeon
H-Index: 5
Eui-Cheol Shin
H-Index: 35
Microfluidic Capture Device for Simple, Cell Surface Marker-Based Quantification of Senescent CD8+ T Cells
BioChip Journal
2024/3/8
Woo-Joong Kim
H-Index: 10
Dongwoo Lee
H-Index: 0
Bum-Joon Jung
H-Index: 2
Eui-Cheol Shin
H-Index: 35
Wonhee Lee
H-Index: 13
Dynamic Responses of Circulating T Cells After Stereotactic Body Radiation Therapy for Bone Metastasis in Patients With Breast Cancer
International Journal of Radiation Oncology* Biology* Physics
2024/3/1
Seung Hyuck Jeon
H-Index: 5
Eui-Cheol Shin
H-Index: 35
Duet of humoral and cellular immunity for conquering hepatitis C virus
2024/2/9
Eui-Cheol Shin
H-Index: 35
IL-15 in T-cell responses and immunopathogenesis
2024/2
Phase I study: safety and efficacy of an ex vivo-expanded allogeneic natural killer cell (MG4101) with rituximab for relapsed/refractory B cell non-hodgkin lymphoma
Transplantation and cellular therapy
2023/4/1
Youngil Koh
H-Index: 4
Eui-Cheol Shin
H-Index: 35
KIR+ CD8+ and NKG2A+ CD8+ T cells are distinct innate-like populations in humans
Cell Reports
2023/3/28
Novel interferon lambda variant and method of producing the same
2023/3/9
Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers
Frontiers in Cellular and Infection Microbiology
2023/3/7
Compact and Efficient Thermoelectric Platform in MoS2
2023/3/6
Eui-Cheol Shin
H-Index: 35
Yong-Hyun Kim
H-Index: 4
A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen
Vaccine
2023/3/3
Corticosteroids reduce pathologic interferon responses by downregulating STAT1 in patients with high-risk COVID-19
Experimental & Molecular Medicine
2023/3
Nanoscale thermoelectric generator using defect-induced Seebeck domain
2023/2/8
Eui-Cheol Shin
H-Index: 35
Yong-Hyun Kim
H-Index: 4
Increased type III interferons and NK cell functions in SARS-CoV-2-infected children
Signal transduction and targeted therapy
2023/2/3
